6th Cannabinoid-Derived Drug Development Summit

With a brand-new agenda, the 6th Cannabinoid-Derived Drug Development Summit is the ideal platform for preclinical and clinical scientists, R and D leaders, and drug developers to keep up with the latest innovations in cannabinoid in vivo and in vitro translation, bioavailability, dosage and delivery, and choosing clinical trial outcomes.

Time: 09:00 – 16:00

Venue details: Hilton Boston Back Bay, 40 Dalton Street, Boston, Massachusetts, 02115, United States

Prices:
Drug Developers | Conference + Workshop: USD 3098.00,
Drug Developers | Conference Only: USD 2599.00,
Solution Providers | Conference + Workshop: USD 4548.00,
Solution Providers | Conference Only: USD 3799.00

Speakers: Adam Kaplin | President and Chief Scientific Officer | Mira Pharmaceuticals, Inc, Andrea Small-Howard | President and Chief Science Officer | GB Sciences, Inc, and more.